Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taro Pharmaceutical Industries Ltd.

https://www.taro.com/

Latest From Taro Pharmaceutical Industries Ltd.

Sun, Execs Settle Whistleblower Charges On Lapses

Sun Pharma and some members of its senior leadership have settled a case pertaining to related party transactions and compliance deviations raised in whistleblower complaints in India.

Commercial Compliance

Sun Sees Indian Market Rebound

90%-95% of specialty doctors are back at their clinics in India and pharma field force personnel are again on the move, though patient footfall is yet to fully normalize, the country’s largest drug firm Sun has indicated. While the situation isn’t quite the same in the US, the company reported sales growth in both key geographies in Q3.

Market Intelligence Strategy

Physicians Return, Field Force Activity Nears Pre-Pandemic Levels In India

90-95% of specialty doctors are back at their clinics in India and pharma field force personnel are again on the move, though patient footfall is yet to fully normalize, the country’s largest drug firm Sun has indicated. While the situation isn’t quite the same in the US, the company reported sales growth in both key geographies in Q3.

Commercial Coronavirus COVID-19

US Recalls: Taro Anti-Fungal Topicals, Wellness Clinic’s Drugs And Supplements, More Sanitizers

FDA records show more than 350,000 tubes of clotrimazole anti-fungal topicals made by Taro's US business for private label and store brands were found with a degradation impurity. An Indiana firm is recalling nutritional supplements and pharmaceuticals it supplied to a wellness center owned by the same person due to “concerns with production processes which cannot assure sterility of products.”

Recalls FDA
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Thallion Pharmaceuticals, Inc.
UsernamePublicRestriction

Register